BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2006
View Archived Issues
Preclinical melanoma, phase I NHL studies of PPI-2458 presented
Read More
Gene therapy approach successful for hip prosthesis loosening
Read More
BioMarin makes strides in third quarter
Read More
Kinases in rheumatology
Read More
Combined ramipril and candesartan better than monotherapy in hypertension
Read More
Rimonabant reduces liver enzymes in overweight, dyslipidemic patients
Read More
Aliskiren reduces renin activity in mono- and combination therapy
Read More
Mitsubishi's novel NF-kB inhibitor shows potent antiangiogenic and antitumor activity in vivo
Read More
Salvat's SVT-004703 shows antitumor activity by inhibiting tubulin polymerization
Read More
MethylGene and EnVivo collaborate with CHDI on Huntington's program
Read More
Roxro's intranasal ketorolac provides effective postsurgery pain relief
Read More
New therapeutic agents for thrombotic disorders disclosed in recent patent literature
Read More
Enrollment suspended in becatecarin phase III program in biliary tract tumors
Read More
Novel agents for obesity, lipoprotein disorders, etc. claimed
Read More
Novel monoclonal antibodies for renal diseases emerge from Lilly R&D
Read More
Clinical advisory meeting for Resverlogix's ApoA-I enhancing technologies
Read More
Emerging companies showcased at BIO-Europe 2006: Ablynx
Read More
Enrollment opens in pivotal MEND-CABG II study of MC-1
Read More
SGN-35 begins phase I study for CD30-positive hematologic malignancies
Read More
EVT-201 begins second phase II trial for insomnia
Read More
Bavituximab studied with chemotherapy in phase Ib cancer study
Read More
Novartis selects preclinical development candidate in Vernalis Hsp90 collaboration
Read More
Actelion to acquire CoTherix
Read More
Gilead Sciences completes Myogen acquisition
Read More
Ferumoxytol meets phase III endpoints in non dialysis-dependent CKD patients
Read More
First DC vaccine with clinical activity and therapeutic/chemopreventive potential
Read More
NeoRecormon recommended for once weekly use in solid tumor patients in E.U.
Read More